rapidli
increas
number
case
name
abnorm
liver
function
frequent
present
patient
aim
clarifi
clinic
featur
liver
damag
provid
refer
clinic
treatment
total
case
analyz
clinic
featur
laboratori
paramet
includ
liver
function
test
medic
length
stay
confirm
patient
femal
male
median
age
year
interquartil
rang
patient
clinic
manifest
fever
cough
expector
admiss
patient
show
abnorm
liver
function
admiss
patient
n
elev
liver
function
index
like
moderatehigh
degre
fever
vs
p
significantli
present
male
patient
vs
p
number
cell
significantli
lower
abnorm
liver
function
group
normal
liver
function
group
statist
differ
prehospit
medic
normal
abnorm
liver
function
group
util
rate
lopinavirritonavir
admiss
significantli
higher
patient
emerg
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
sinc
decemb
novel
coronaviru
identifi
pathogen
caus
pneumonia
wuhan
china
temporarili
name
februari
base
phylogeni
taxonomi
establish
practic
offici
name
diseas
caus
name
evid
proven
transmit
person
person
respiratori
droplet
close
contact
pose
huge
challeng
public
health
seventi
thousand
confirm
case
two
thousand
death
case
countri
around
world
main
manifest
infect
includ
fever
dri
cough
weak
breath
difficulti
abnorm
liver
function
frequent
report
extrapulmonari
clinic
featur
almost
one
half
patient
experienc
differ
degre
liver
function
damag
accord
recent
studi
singlecel
rnaseq
angiotensin
convert
enzym
ace
highli
express
type
ii
alveolar
epitheli
cell
also
bile
duct
cell
importantli
recent
studi
confirm
cell
entri
receptor
like
sarscov
receptor
find
suggest
may
infect
bile
duct
cell
caus
abnorm
liver
function
patient
howev
alkalin
phosphatas
alp
bile
duct
injuri
relat
index
specif
patient
recent
patholog
find
report
moder
microvascular
steatosi
mild
lobular
portal
activ
present
liver
biopsi
specimen
indic
liver
injuri
could
caus
either
infect
druginduc
liver
injuri
current
howev
clinic
research
analyz
whether
abnorm
liver
function
patient
due
drug
use
given
high
contagi
pathogen
capac
high
incid
liver
damag
analysi
liver
function
covid
patient
urgent
warrant
studi
retrospect
investig
liver
function
chang
patient
singl
center
studi
shanghai
china
compar
clinic
featur
medic
length
stay
patient
withwithout
liver
damag
purpos
studi
clarifi
clinic
featur
liver
damag
evalu
associ
current
medic
liver
damag
therefor
provid
refer
clinic
treatment
patient
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
januari
januari
total
consecut
patient
admit
treat
shanghai
public
health
clinic
center
affili
fudan
univers
design
hospit
shanghai
area
confirm
case
clinic
criteria
diagnosi
discharg
refer
standard
diagnosi
treatment
scheme
new
coronaviru
infect
pneumonia
trial
version
case
histori
relat
epidemiolog
clinic
manifest
fever
respiratori
symptom
patient
diagnos
examin
rna
rtpcr
chest
ct
scan
februari
case
discharg
hospit
die
period
averag
length
hospit
discharg
case
day
day
studi
approv
ethic
committe
shanghai
public
health
clinic
center
review
date
jan
exempt
need
inform
consent
patient
medic
record
patient
collect
analyz
research
team
depart
gastroenterolog
hepatolog
shanghai
public
health
clinic
center
fudan
univers
epidemiolog
clinic
laboratori
characterist
treatment
outcom
data
acquir
hospit
manag
system
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
sera
harvest
confirm
patient
overnight
fast
laboratori
data
obtain
day
sera
extract
laboratori
patient
rest
bed
receiv
nutrit
support
basic
principl
treatment
symptomat
treatment
maintain
balanc
water
electrolyt
stabl
intern
environ
monitor
vital
sign
finger
oxygen
satur
give
effect
oxygen
therapi
time
antivir
therapi
tri
interferon
lopinavirlitonavir
abidol
dnrunavir
antibiot
use
necessari
continu
measur
compar
student
test
mannwhitney
u
test
normal
distribut
present
mean
standard
deviat
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
sd
abnorm
distribut
measur
median
inter
quartil
rang
respect
categor
variabl
shown
percentag
compar
use
chisquar
analysi
fisher
exact
test
p
determin
statist
signific
differ
statist
analysi
softwar
graphpad
prism
use
analys
studi
funder
studi
role
studi
design
data
collect
data
analysi
data
interpret
write
report
correspond
author
full
access
data
studi
final
respons
decis
submit
public
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
januari
total
case
admit
tabl
compar
patient
normal
liver
function
n
patient
elev
liver
function
index
n
like
moderatehigh
degre
fever
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
vs
p
significantli
present
male
vs
p
medic
patient
admiss
includ
antibiot
levofloxacin
azithromycin
cephalosporin
antivir
drug
arbidol
oseltamivir
acyclovir
convent
febrifug
ibuprofen
statist
differ
prehospit
treatment
two
group
tabl
number
lymphocyt
abnorm
liver
function
group
significantli
lower
normal
liver
function
group
shown
tabl
number
cell
lower
abnorm
liver
function
group
compar
normal
liver
function
group
moreov
level
pct
crp
also
observ
increas
abnorm
liver
function
group
normal
liver
function
group
observ
patient
normal
liver
function
liver
injuri
around
day
admiss
probabl
stay
hospit
patient
receiv
treatment
antibiot
levofloxacin
meropenem
moxifloxacin
cephalosporin
interferon
antivir
drug
arbidol
lopinavirritonavir
dnrunavir
statist
differ
hospit
treatment
two
group
term
antibiot
interferon
use
clinic
practic
howev
found
patient
abnorm
liver
function
receiv
treatment
lopinavirritonavir
compar
normal
liver
function
p
tabl
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
februari
total
patient
discharg
hospit
includ
case
abnorm
liver
function
admiss
case
emerg
abnorm
liver
function
hospit
case
normal
liver
function
stay
hospit
note
found
liver
function
relat
index
admiss
littl
effect
hospit
stay
patient
emerg
abnorm
liver
function
admiss
prolong
length
stay
tabl
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
nearli
half
patient
studi
year
old
consist
previou
report
howev
signific
differ
preval
men
women
anoth
studi
includ
case
demonstr
incid
higher
male
femal
patient
present
fever
similar
report
howev
fever
inevit
manifest
infect
even
case
asymptomat
patient
studi
activ
hospit
close
contact
confirm
case
diagnos
recent
case
report
asymptomat
carrier
without
symptom
sign
transmit
coronaviru
five
person
undoubt
asymptomat
patient
increas
challeng
prevent
infect
therefor
pay
close
attent
asymptomat
highrisk
group
clinic
diagnosi
treatment
studi
need
explor
underli
mechan
wherebi
asymptomat
patient
could
exist
notabl
half
patient
admiss
present
abnorm
liver
function
seem
noth
clinic
medic
proport
increas
alp
lowest
patient
liver
function
injuri
incid
increas
alp
also
lowest
patient
admit
hospit
similar
previou
studi
although
highli
express
bile
duct
cell
recent
work
suggest
infect
caus
increas
marker
bile
duct
injuri
alp
exclus
rel
speak
elev
marker
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
liver
cell
injuri
alt
ast
common
approxim
one
five
patient
studi
elev
alt
ast
slightli
lower
earlier
studi
moverev
level
elev
alt
ast
gener
high
admiss
studi
indic
relat
liver
injuri
seriou
initi
stage
infect
find
consist
previou
research
studi
found
liver
damag
common
patient
sever
pneumonia
suspect
associ
inflammatori
factor
storm
explain
fact
also
liver
damag
mild
patient
mani
similar
outbreak
sarscov
literatur
review
refer
autopsi
analysi
patient
die
sever
acut
respiratori
syndrom
sar
addit
lung
immun
system
sever
damag
fatti
degener
central
lobular
necrosi
sarscov
detect
liver
reason
believ
also
attack
human
liver
addit
worth
note
ldh
frequent
increas
studi
accord
exist
studi
proport
increas
ldh
case
wuhan
accord
previou
research
level
ldh
patient
sar
mer
also
increas
level
ldh
patient
independ
risk
factor
sar
due
poor
specif
ldh
may
relat
lung
skelet
muscl
myocardium
fulli
repres
liver
function
compar
relationship
ldh
level
heat
degre
patient
found
ldh
patient
moderatehigh
fever
significantli
higher
compar
patient
low
fever
normal
temperatur
data
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
shown
whether
ldh
use
earli
alarm
factor
need
analysi
although
also
seriou
liver
injuri
report
concomit
chronic
liver
diseas
could
nt
exclud
case
chronic
hepat
b
c
studi
statist
differ
proport
chronic
liver
diseas
abnorm
liver
function
group
normal
liver
function
group
effect
antivir
drug
avail
symptomat
support
treatment
rather
crucial
mani
patient
appli
antivir
antipyret
drug
howev
antivir
drug
acetaminophen
advers
reaction
liver
function
injuri
previou
studi
analyz
whether
patient
abnorm
liver
function
caus
infect
drug
use
studi
drug
use
patient
admiss
mainli
antibacteri
drug
includ
moxifloxacin
cephalosporin
antivir
drug
abidol
oseltamivir
acyclovir
antipyret
drug
acetaminophen
analyz
prehospit
medic
two
group
found
statist
differ
two
group
therefor
specul
liver
function
damag
patient
close
relat
viru
infect
addit
proport
male
patient
liver
damag
larg
specif
mechan
unclear
bodi
temperatur
patient
liver
damag
significantli
higher
control
group
may
relat
immun
respons
viru
infect
patient
liver
damag
higher
inflammatori
index
elev
crp
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
basic
consist
anoth
studi
reduct
function
exhaust
cell
found
patient
howev
direct
relationship
decreas
cell
count
liver
damag
remain
unclear
admiss
part
case
normal
liver
function
develop
liver
function
injuri
compar
medic
patient
hospit
studi
found
applic
rate
lopinavirritonavir
liver
damag
group
significantli
higher
patient
normal
liver
function
length
stay
patient
liver
damag
admiss
significantli
longer
case
normal
liver
function
view
anoth
articl
antivir
effect
hospit
lopinavirritonavir
effect
neg
convers
rate
reason
tend
recommend
lopinavirritonavir
common
clinic
treatment
drug
even
mild
patient
normal
liver
function
studi
need
evalu
risk
benefit
lopinavirritonavir
may
bring
howev
also
defici
research
studi
retrospect
case
incomplet
document
histori
present
ill
moreov
data
collect
singl
center
certain
timepoint
sampl
size
rel
limit
furthermor
direct
evid
abnorm
liver
function
caus
yet
verifi
studi
need
corrobor
pathogen
mechan
conclus
first
time
analyz
clinic
featur
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
liver
injuri
relationship
clinic
medic
liver
damag
patient
may
caus
liver
function
damag
emerg
liver
injuri
admiss
connect
applic
lopinavirritonavir
extend
length
hospit
stay
find
expect
provid
refer
clinic
treatment
current
epidem
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
figur
proport
incid
rate
normalabnorm
liver
function
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
